The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ferric carboxymaltose Teva 50 mg iron/ml dispersion for injection/infusion

Teva B.V.PA1986/124/001

Main Information

Trade NameFerric carboxymaltose Teva 50 mg iron/ml dispersion for injection/infusion
Active SubstancesFerric carboxymaltose
Dosage FormDispersion for injection/infusion
Licence HolderTeva B.V.
Licence NumberPA1986/124/001

Group Information

ATC CodeB03AC Iron, parenteral preparations


License statusAuthorised
Licence Issued24/05/2024
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back